Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Heqet Therapeutics s.r.l.
See Emerging Company Profile .
BioCentury | Jun 4, 2022
Emerging Company Profile
Heqet: regenerating heart muscle cells via the Hippo pathway
King’s College spinout is inducing cardiomyocyte regeneration via nanoparticle-delivered miRNA
BioCentury | May 9, 2022
Data Byte
Italian seed and series A financings since 2020
At least 12 Italian start-ups have attracted seed or series A funding since 2020, with Sofinnova and Claris the most active VCs
Items per page:
1 - 2 of 2